Not applicableUnknownNCT03883542What this trial is testingSub-type Specific Genomic Mutations in sBOTsWho this might be right forOvarian Neoplasm Epithelial Universitair Ziekenhuis Brussel 20
Testing effectiveness (Phase 2)Study completedNCT00551070What this trial is testingSelumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum CancerWho this might be right forBorderline Ovarian Serous TumorLow Grade Ovarian Serous AdenocarcinomaMicropapillary Serous Carcinoma+3 more National Cancer Institute (NCI) 52
Early research (Phase 1)Study completedNCT02520115What this trial is testingFolate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian CancerWho this might be right forAdnexal MassBorderline Ovarian Epithelial TumorOvarian Clear Cell Tumor+4 more Barbara Ann Karmanos Cancer Institute 50
Not applicableUnknownNCT02408536What this trial is testingObservational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian CancerWho this might be right forLow-grade Serous Ovarian CarcinomaRecurrent Invasive Borderline Serous Ovarian Cancer National Cancer Institute, Naples 150
Large-scale testing (Phase 3)Study completedNCT02101788What this trial is testingTrametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity CancerWho this might be right forBorderline Ovarian Serous TumorMicropapillary Serous CarcinomaOvarian Serous Adenocarcinoma+3 more National Cancer Institute (NCI) 260
Early research (Phase 1)Study completedNCT00006981What this trial is testingImmunotoxin Therapy in Treating Patients With Advanced CancerWho this might be right forCervical CancerFallopian Tube CancerHead and Neck Cancer+5 more National Cancer Institute (NCI)
Not applicableStudy completedNCT00897442What this trial is testingCollecting Tumor Samples From Patients With Gynecological TumorsWho this might be right forBorderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more Gynecologic Oncology Group 275
Testing effectiveness (Phase 2)Looking for participantsNCT05500391What this trial is testingAssessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote MonitoringWho this might be right forStage I Testicular SeminomaStage I Testicular Nonseminomatous Germ Cell TumorGastrointestinal Stromal Tumors+11 more Centre Oscar Lambret 88